{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:16:12Z","timestamp":1790702172626,"version":"4.1.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T00:00:00Z","timestamp":1596931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jaci.2020.07.015","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T07:07:11Z","timestamp":1599203231000},"page":"467-478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"title":["Neonatal Fc receptor in human immunity: Function and role in therapeutic intervention"],"prefix":"10.1016","volume":"146","author":[{"given":"Dhavalkumar D.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Bussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2020.07.015_bib1","series-title":"Immunobiology: the immune system in health and disease","article-title":"The humoral immune response","author":"Janeway","year":"2001"},{"key":"10.1016\/j.jaci.2020.07.015_bib2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib3","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.3389\/fimmu.2019.01540","article-title":"The neonatal Fc receptor (FcRn): a misnomer?","volume":"10","author":"Pyzik","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib4","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1073\/pnas.1817341116","article-title":"The neonatal Fc receptor is a pan-echovirus receptor","volume":"116","author":"Morosky","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2020.07.015_bib5","first-page":"1","article-title":"Metabolism of immunoglobulins","volume":"13","author":"Waldmann","year":"1969","journal-title":"Prog Allergy"},{"key":"10.1016\/j.jaci.2020.07.015_bib6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1469-185X.1958.tb01412.x","article-title":"The passive immunity of the young mammal","volume":"33","author":"Brambell","year":"1958","journal-title":"Biol Rev"},{"key":"10.1016\/j.jaci.2020.07.015_bib7","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/2031352a0","article-title":"A theoretical model of gamma-globulin catabolism","volume":"203","author":"Brambell","year":"1964","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2020.07.015_bib8","doi-asserted-by":"crossref","first-page":"159s","DOI":"10.1083\/jcb.99.1.159s","article-title":"Receptor-mediated transport of IgG","volume":"99","author":"Rodewald","year":"1984","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jaci.2020.07.015_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/337184a0","article-title":"An Fc receptor structurally related to MHC class I antigens","volume":"337","author":"Simister","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2020.07.015_bib10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/eji.1830150718","article-title":"Isolation and characterization of an Fc receptor from neonatal rat small intestine","volume":"15","author":"Simister","year":"1985","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1084\/jem.20021829","article-title":"The major histocompatibility complex\u2013related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan","volume":"197","author":"Chaudhury","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2020.07.015_bib12","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3389\/fimmu.2014.00682","article-title":"Unraveling the interaction between FcRn and albumin: opportunities for design of albumin-based therapeutics","volume":"5","author":"Sand","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib13","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1021\/bi052628y","article-title":"Albumin binding to FcRn: distinct from the FcRn-IgG interaction","volume":"45","author":"Chaudhury","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.jaci.2020.07.015_bib14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/372379a0","article-title":"Crystal structure of the complex of rat neonatal Fc receptor with Fc","volume":"372","author":"Burmeister","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2020.07.015_bib15","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1006\/jmbi.1993.1220","article-title":"Crystallization and stoichiometry of binding of a complex between a rat intestinal Fc receptor and Fc","volume":"230","author":"Huber","year":"1993","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jaci.2020.07.015_bib16","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1021\/bi9907330","article-title":"Stoichiometry of the interaction between the major histocompatibility complex-related Fc receptor and its Fc ligand","volume":"38","author":"Sanchez","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.jaci.2020.07.015_bib17","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0161-5890(99)00093-0","article-title":"Sedimentation equilibrium analysis of recombinant mouse FcRn with murine IgG1","volume":"36","author":"Schuck","year":"1999","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib18","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1073\/pnas.93.11.5512","article-title":"The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor","volume":"93","author":"Junghans","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2020.07.015_bib19","doi-asserted-by":"crossref","first-page":"928","DOI":"10.4161\/mabs.28744","article-title":"Characterization and screening of IgG binding to the neonatal Fc receptor","volume":"6","author":"Neuber","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.jaci.2020.07.015_bib20","doi-asserted-by":"crossref","first-page":"14649","DOI":"10.1021\/bi00045a005","article-title":"Analysis of the pH dependence of the neonatal Fc receptor\/immunoglobulin G interaction using antibody and receptor variants","volume":"34","author":"Raghavan","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.jaci.2020.07.015_bib21","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1083\/jcb.71.2.666","article-title":"pH-dependent binding of immunoglobulins to intestinal cells of the neonatal rat","volume":"71","author":"Rodewald","year":"1976","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jaci.2020.07.015_bib22","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1074\/jbc.M113.537563","article-title":"Structural insights into neonatal Fc receptor-based recycling mechanisms","volume":"289","author":"Oganesyan","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2020.07.015_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0969-2126(98)00008-2","article-title":"Structural basis of pH-dependent antibody binding by the neonatal Fc receptor","volume":"6","author":"Vaughn","year":"1998","journal-title":"Structure"},{"key":"10.1016\/j.jaci.2020.07.015_bib24","article-title":"The ligands for human IgG and their effector functions","volume":"8","author":"de Taeye","year":"2019","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.jaci.2020.07.015_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/intimm\/dxg018","article-title":"Evidence to support the cellular mechanism involved in serum IgG homeostasis in humans","volume":"15","author":"Ward","year":"2003","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib26","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.4049\/jimmunol.172.4.2021","article-title":"Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor","volume":"172","author":"Ober","year":"2004","journal-title":"FcRn. J Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib27","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1182\/blood.2019001133","article-title":"FcRn augments induction of tissue factor activity by IgG-containing immune complexes","volume":"135","author":"Cines","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.07.015_bib28","first-page":"217","article-title":"FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex-driven autoimmunity","author":"Hubbard","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2020.07.015_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF00915364","article-title":"Correlation of in\u00a0vitro antibody synthesis with the outcome of intravenous gamma-globulin treatment of chronic idiopathic thrombocytopenic purpura","volume":"6","author":"Bussel","year":"1986","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib30","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ncomms1608","article-title":"Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential","volume":"2","author":"Stapleton","year":"2011","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2020.07.015_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaci.2020.07.016","article-title":"Targeting FcRn for immunomodulation: benefits, risks, and practical considerations","volume":"146","author":"Peter","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib32","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3389\/fimmu.2014.00664","article-title":"Regulation of immune responses by the neonatal fc receptor and its therapeutic implications","volume":"5","author":"Rath","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12972","article-title":"Expression of FcRn receptor in placental tissue and its relationship with IgG levels in term and preterm newborns","volume":"80","author":"Lozano","year":"2018","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib34","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1172\/JCI6968","article-title":"Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line","volume":"104","author":"Dickinson","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2020.07.015_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2567.1997.00326.x","article-title":"Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells","volume":"92","author":"Israel","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2020.07.015_bib36","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s11095-013-1212-3","article-title":"Human and non-human primate intestinal FcRn expression and immunoglobulin G transcytosis","volume":"31","author":"Hornby","year":"2014","journal-title":"Pharm Res"},{"key":"10.1016\/j.jaci.2020.07.015_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.20020400","article-title":"Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung","volume":"196","author":"Spiekermann","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2020.07.015_bib38","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.it.2015.09.008","article-title":"Antibodies as mediators of brain pathology","volume":"36","author":"Brimberg","year":"2015","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib39","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1681\/ASN.V114632","article-title":"Characterization and localization of the neonatal Fc receptor in adult human kidney","volume":"11","author":"Haymann","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaci.2020.07.015_bib40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/j.1879-3479.1978.tb00410.x","article-title":"Serum immunoglobulin levels in normal, premature and postmature newborns and their mothers","volume":"16","author":"Salimonu","year":"1978","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jaci.2020.07.015_bib41","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/intimm\/13.8.993","article-title":"The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans","volume":"13","author":"Firan","year":"2001","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib42","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.4049\/jimmunol.157.8.3317","article-title":"Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport","volume":"157","author":"Leach","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib43","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/eji.1830260718","article-title":"An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta","volume":"26","author":"Simister","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib44","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1651-2227.1967.tb15982.x","article-title":"Immunoglobulin levels in healthy children","volume":"56","author":"Johansson","year":"1967","journal-title":"Acta P\u00e6diatrica"},{"key":"10.1016\/j.jaci.2020.07.015_bib45","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1542\/peds.37.5.715","article-title":"Serum levels of immune globulins in health and disease: a survey","volume":"37","author":"Stiehm","year":"1966","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2020.07.015_bib46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1369\/0022155417705095","article-title":"Distribution of FcRn across species and tissues","volume":"65","author":"Latvala","year":"2017","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.jaci.2020.07.015_bib47","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41385-019-0227-4","article-title":"IgA and the intestinal microbiota: the importance of being specific","volume":"13","author":"Pabst","year":"2020","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib48","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2013.08.035","article-title":"Efflux of monoclonal antibodies from rat brain by neonatal Fc receptor","volume":"1534","author":"Cooper","year":"2013","journal-title":"FcRn. Brain Res"},{"key":"10.1016\/j.jaci.2020.07.015_bib50","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1046\/j.1471-4159.2001.00222.x","article-title":"Rapid transferrin efflux from brain to blood across the blood\u2013brain barrier","volume":"76","author":"Zhang","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.jaci.2020.07.015_bib51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1471-4159.2002.00840.x","article-title":"Expression of the neonatal Fc receptor (FcRn) at the blood-brain barrier","volume":"81","author":"Schlachetzki","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.jaci.2020.07.015_bib52","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1073\/pnas.0711515105","article-title":"Podocytes use FcRn to clear IgG from the glomerular basement membrane","volume":"105","author":"Akilesh","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2020.07.015_bib53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/cei.12729","article-title":"Immunology of membranous nephropathy: from animal models to humans","volume":"183","author":"Sinico","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib54","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1681\/ASN.2013050498","article-title":"Neonatal Fc receptor promotes immune complex-mediated glomerular disease","volume":"25","author":"Olaru","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaci.2020.07.015_bib55","doi-asserted-by":"crossref","first-page":"F358","DOI":"10.1152\/ajprenal.0164.2001","article-title":"FcRn-mediated transcytosis of immunoglobulin G in human renal proximal tubular epithelial cells","volume":"282","author":"Kobayashi","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jaci.2020.07.015_bib56","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1681\/ASN.2013010018","article-title":"Albumin is recycled from the primary urine by tubular transcytosis","volume":"24","author":"Tenten","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaci.2020.07.015_bib57","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.4049\/jimmunol.166.5.3266","article-title":"MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells","volume":"166","author":"Zhu","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib58","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1073\/pnas.0801717105","article-title":"Dependence of antibody-mediated presentation of antigen on FcRn","volume":"105","author":"Qiao","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2020.07.015_bib59","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fimmu.2014.00408","article-title":"The role of FcRn in antigen presentation","volume":"5","author":"Baker","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib60","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1073\/pnas.0600548103","article-title":"Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant beta2-microglobulin gene","volume":"103","author":"Wani","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2020.07.015_bib61","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1172\/JCI114947","article-title":"Familial hypercatabolic hypoproteinemia: a disorder of endogenous catabolism of albumin and immunoglobulin","volume":"86","author":"Waldmann","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2020.07.015_bib62","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2567.2006.02408.x","article-title":"A variable number of tandem repeats polymorphism influences the transcriptional activity of the neonatal Fc receptor alpha-chain promoter","volume":"119","author":"Sachs","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2020.07.015_bib63","first-page":"609","article-title":"Association between polymorphisms in the FCGRT gene and lupus nephritis in Chinese patients","volume":"27","author":"Zhou","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaci.2020.07.015_bib64","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4161\/mabs.24815","article-title":"Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies","volume":"5","author":"Passot","year":"2013","journal-title":"MAbs"},{"key":"10.1016\/j.jaci.2020.07.015_bib65","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s10875-010-9458-6","article-title":"Clinical ramifications of the MHC family Fc receptor FcRn","volume":"30","author":"Roopenian","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib66","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/acn3.307","article-title":"Neonatal Fc receptor promoter gene polymorphism does not predict pharmacokinetics of IVIg or the clinical course of GBS","volume":"3","author":"Fokkink","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jaci.2020.07.015_bib67","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s40262-016-0406-3","article-title":"Bevacizumab pharmacokinetics influence overall and progression-free survival in metastatic colorectal cancer patients","volume":"55","author":"Caulet","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jaci.2020.07.015_bib68","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/ajg.2016.306","article-title":"A genetic variation in the neonatal Fc-receptor affects anti-TNF drug concentrations in inflammatory bowel disease","volume":"111","author":"Billiet","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2020.07.015_bib69","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/cei.12002","article-title":"Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor","volume":"171","author":"Gouilleux-Gruart","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib70","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.3928\/00904481-20150512-09","article-title":"Nonpolio enterovirus infections in neonates","volume":"44","author":"Haston","year":"2015","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.jaci.2020.07.015_bib71","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.siny.2009.02.002","article-title":"Enterovirus infections in neonates","volume":"14","author":"Tebruegge","year":"2009","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.jaci.2020.07.015_bib72","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.cell.2019.04.035","article-title":"Human neonatal Fc receptor is the cellular uncoating receptor for enterovirus B","volume":"177","author":"Zhao","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2020.07.015_bib73","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ncprheum0895","article-title":"Nature and functions of autoantibodies","volume":"4","author":"Elkon","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.jaci.2020.07.015_bib74","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1750-1172-2-44","article-title":"Myasthenia gravis","volume":"2","author":"Juel","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaci.2020.07.015_bib75","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJM198105073041904","article-title":"Chronic idiopathic thrombocytopenic purpura","volume":"304","author":"McMillan","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.07.015_bib76","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.autrev.2014.11.006","article-title":"Goodpasture\u2019s syndrome: a clinical update","volume":"14","author":"Greco","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaci.2020.07.015_bib77","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/0003-4819-87-2-210","article-title":"Pathophysiology of immune hemolytic anemia","volume":"87","author":"Frank","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2020.07.015_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/2e462817-ab93-4d78-95a4-1d8b9d172971","article-title":"Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis","volume":"7","author":"Sokolove","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2020.07.015_bib79","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJM199805073381906","article-title":"Antibodies to DNA","volume":"338","author":"Hahn","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.07.015_bib80","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.amjmed.2015.02.017","article-title":"Cryoglobulinemia vasculitis","volume":"128","author":"Cacoub","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2020.07.015_bib81","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/nyas.13561","article-title":"IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders","volume":"1413","author":"Huijbers","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaci.2020.07.015_bib82","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.bbadis.2017.07.038","article-title":"On the role of IgG4 in inflammatory conditions: lessons for IgG4-related disease","volume":"1864","author":"Trampert","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jaci.2020.07.015_bib83","series-title":"Transfusion handbook","author":"Norfolk","year":"2013"},{"key":"10.1016\/j.jaci.2020.07.015_bib84","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jaci.2020.07.015_bib85","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/08916934.2016.1214823","article-title":"Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis","volume":"49","author":"Guptill","year":"2016","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaci.2020.07.015_bib86","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jca.21562","article-title":"Critical updates in the 7th edition of the American Society for Apheresis guidelines","volume":"33","author":"Ipe","year":"2018","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jaci.2020.07.015_bib87","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/asheducation.V2012.1.7.3797920","article-title":"Plasma exchange: concepts, mechanisms, and an overview of the American Society for Apheresis guidelines","volume":"2012","author":"Winters","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jaci.2020.07.015_bib88","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archneur.63.7.930","article-title":"Plasma exchange in neuroimmunological disorders: part 1: rationale and treatment of inflammatory central nervous system disorders","volume":"63","author":"Lehmann","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jaci.2020.07.015_bib89","doi-asserted-by":"crossref","first-page":"363","DOI":"10.14503\/THIJ-15-5672","article-title":"Use of an intravascular warming catheter during off-pump coronary artery bypass surgery in a patient with severe cold hemagglutinin disease","volume":"43","author":"Tholpady","year":"2016","journal-title":"Texas Heart Inst J"},{"key":"10.1016\/j.jaci.2020.07.015_bib90","series-title":"Blood banking and transfusion medicine: basic principles and practice","author":"Hillyer","year":"2006"},{"key":"10.1016\/j.jaci.2020.07.015_bib91","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/jca.2920100410","article-title":"Immunologic rebound","volume":"10","author":"Dau","year":"1995","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jaci.2020.07.015_bib92","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/biom6010015","article-title":"The production processes and biological effects of intravenous immunoglobulin","volume":"6","author":"Barahona Afonso","year":"2016","journal-title":"Biomolecules"},{"issue":"Suppl 3","key":"10.1016\/j.jaci.2020.07.015_bib93","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00415-008-3002-0","article-title":"Advances in the understanding of the mechanism of action of IVIg","volume":"255","author":"Hartung","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.jaci.2020.07.015_bib94","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(81)92400-4","article-title":"High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood","volume":"1","author":"Imbach","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2020.07.015_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2005.02834.x","article-title":"Clinical uses of intravenous immunoglobulin","volume":"142","author":"Jolles","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib96","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2016.09.023","article-title":"Update on the use of immunoglobulin in human disease: a review of evidence","volume":"139","author":"Perez","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib97","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jaci.2020.06.036","article-title":"Dissecting the mechanism of action of intravenous immunoglobulin in human autoimmune disease: lessons from therapeutic modalities targeting Fc\u03b3 receptors","volume":"146","author":"Shock","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib98","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood.V62.2.480.480","article-title":"Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura","volume":"62","author":"Bussel","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.07.015_bib101","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan1208","article-title":"The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: a randomized phase 1 study","volume":"9","author":"Kiessling","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2020.07.015_bib102","first-page":"1111","article-title":"Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration","volume":"10","author":"Smith","year":"2018","journal-title":"MAbs"},{"key":"10.1016\/j.jaci.2020.07.015_bib103","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2020002003","article-title":"Phase 2 multiple dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia (ITP)","author":"Robak","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaci.2020.07.015_bib104","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.92.15_supplement.S43.001","article-title":"Proof-of-concept and safety of the anti-FcRn antibody rozanolixizumab in patients with moderate-to-severe generalized myasthenia gravis (GMG): a phase 2a study","author":"Bril","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jaci.2020.07.015_bib105","doi-asserted-by":"crossref","first-page":"e2661","DOI":"10.1212\/WNL.0000000000007600","article-title":"Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis","volume":"92","author":"Howard","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jaci.2020.07.015_bib106","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ajh.25680","article-title":"Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia","volume":"95","author":"Newland","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaci.2020.07.015_bib107","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/cpt.1276","article-title":"M281, an anti-FcRn antibody: pharmacodynamics, pharmacokinetics, and safety across the full range of IgG reduction in a first-in-human study","volume":"105","author":"Ling","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaci.2020.07.015_bib108","doi-asserted-by":"crossref","first-page":"498.e1","DOI":"10.1016\/j.ajog.2019.02.058","article-title":"M281, an anti-FcRn antibody, inhibits IgG transfer in a human ex\u00a0vivo placental perfusion model","volume":"220","author":"Roy","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaci.2020.07.015_bib109","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.92.15_supplement.P5.2-079","article-title":"RVT-1401, a novel anti-FcRn monoclonal antibody, is well tolerated in healthy subjects and reduces plasma IgG following subcutaneous or intravenous administration","volume":"92","author":"Collins","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jaci.2020.07.015_bib110","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax9586","article-title":"Blocking FcRn in humans reduces circulating IgG levels and inhibits IgG immune complex-mediated immune responses","volume":"5","author":"Blumberg","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.jaci.2020.07.015_bib111","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.jid.2018.03.546","article-title":"538 FcRn blockade with SYNT001 for the treatment of pemphigus","volume":"138","author":"Werth","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2020.07.015_bib112","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.expneurol.2019.03.001","article-title":"Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis","volume":"317","author":"Huijbers","year":"2019","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jaci.2020.07.015_bib113","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1172\/JCI97911","article-title":"Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans","volume":"128","author":"Ulrichts","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2020.07.015_bib114","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.intimp.2018.11.040","article-title":"Generation of two high affinity anti-mouse FcRn antibodies: inhibition of IgG recycling in wild type mice and effect in a mouse model of immune thrombocytopenia","volume":"66","author":"Smith","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaci.2020.07.015_bib115","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.4049\/jimmunol.178.8.5390","article-title":"Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade","volume":"178","author":"Liu","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib116","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/bph.14986","article-title":"Treatment with anti-neonatal Fc receptor (FcRn) antibody ameliorates experimental\u00a0epidermolysis bullosa acquisita in mice","volume":"177","author":"Kasprick","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jaci.2020.07.015_bib117","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4161\/mabs.25439","article-title":"Autoantibody depletion ameliorates disease in murine experimental autoimmune encephalomyelitis","volume":"5","author":"Challa","year":"2013","journal-title":"MAbs"},{"key":"10.1016\/j.jaci.2020.07.015_bib118","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.4049\/jimmunol.1003780","article-title":"Neonatal Fc receptor blockade by Fc engineering ameliorates arthritis in a murine model","volume":"187","author":"Patel","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.07.015_bib119","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/j.ajkd.2008.02.360","article-title":"Therapeutic plasma exchange: core curriculum 2008","volume":"52","author":"Kaplan","year":"2008","journal-title":"Am J Kidney Dis"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920310368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920310368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:26:14Z","timestamp":1758792374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674920310368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":117,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0091674920310368"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2020.07.015","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neonatal Fc receptor in human immunity: Function and role in therapeutic intervention","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2020.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}